EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for PFE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 0.7552
March 31, 2026 1.304
December 31, 2025 1.355
September 30, 2025 1.716
June 30, 2025 1.880
March 31, 2025 1.378
December 31, 2024 1.407
September 30, 2024 0.7439
June 30, 2024 -0.4641
March 31, 2024 -0.0606
December 31, 2023 0.3594
September 30, 2023 1.821
June 30, 2023 3.754
March 31, 2023 5.074
December 31, 2022 5.474
September 30, 2022 5.193
June 30, 2022 5.109
March 31, 2022 4.402
December 31, 2021 3.896
September 30, 2021 3.458
June 30, 2021 2.293
March 31, 2021 1.893
December 31, 2020 1.629
September 30, 2020 1.418
June 30, 2020 2.518
Date Value
March 31, 2020 2.787
December 31, 2019 2.869
September 30, 2019 2.86
June 30, 2019 2.19
March 31, 2019 1.95
December 31, 2018 1.86
September 30, 2018 3.95
June 30, 2018 3.73
March 31, 2018 3.59
December 31, 2017 3.51
September 30, 2017 1.62
June 30, 2017 1.37
March 31, 2017 1.19
December 31, 2016 1.17
September 30, 2016 1.01
June 30, 2016 1.13
March 31, 2016 1.22
December 31, 2015 1.11
September 30, 2015 1.335
June 30, 2015 1.411
March 31, 2015 1.443
December 31, 2014 1.412
September 30, 2014 1.616
June 30, 2014 1.593
March 31, 2014 1.659

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Johnson & Johnson 8.628
Eli Lilly & Co. 29.43
Merck & Co., Inc. 1.251
Bristol Myers Squibb Co. 4.539
Viatris, Inc. -0.3572